Aureon Biosciences is seeking two experienced MD or MD, PhD Pathologists who are Board certified (AP or AP/CP) with licensure in the New York/Tri-State region. Subspecialty/expertise in uropathology, breast pathology and cytology is desirable. The ideal candidates are accomplished, mid-career anatomic pathologists with particular interest in enhancing morphologic observations with methods to further extract information from paraffin sections (e.g., morphometry, biomarker localization), and who would be attracted by the challenge and potential of the integrated analytical approach of Systems Pathology.
While both successful candidates shall be expected to interact regularly with the scientists in the Molecular and Biomarker Technologies, as well as the mathematicians and biostatisticians in the Machine Vision and Machine Learning divisions, one (the service Pathologist) shall be primarily concerned with the evaluation, processing and reporting of specimens for our commercial predictive prostate cancer tests; the other shall be primarily involved in research and development.
The service Pathologist shall be responsible for the accurate and timely evaluation of surgical specimens, for generating and evaluating pathological, morphometric and biomarker data for patients or assigned studies, through direct/indirect supervision of individuals assigned to studies. In addition he/she will oversee QC/QA programs to insure compliance with CAP, DOH and other accreditation programs.
The R&D Pathologist is expected to participate in the evaluation and implementation of new techniques and approaches to molecular oncology and/or of new procedures. A current knowledge of recent advances and new equipment/procedures (e.g., immunohistochemistry, immunofluorescence, image analysis, in situ hybridization, laser capture microscopy, quantum dots, quantitative PCR, multiplex assays, etc.) is expected. He/she will participate in the design and implementation of complex projects requiring the most advanced interpretive experience and knowledge.
Qualifications:
- MD degree with Pathology Board certification and experience in molecular pathology. GU experience is desirable
- Ability to work on multiple projects and under strict deadlines
- Ability to work in a team environment
- Excellent oral/written/presentation communication skills
- Demonstrated ability to communicate effectively with others.
This position is located in our Yonkers, New York office.
Candidates who are planning additional subspecialty fellowship training are strongly encouraged to apply. Our company is planning to progressively fill multiple subspecialty positions over the next 1-4 years as we continue to expand. Please submit a summary of experience, CV, names of three (3) references and salary history to recruiter@aureon.com or fax to 914-377-4001.
Who is Aureon?
Aureon Biosciences is dedicated to enabling the advancement of predictive and personalized cancer treatment by performing diagnostic reference laboratory and clinical research services. Aureon incorporates Systems Pathology, a method that predicts individual clinical outcomes by analyzing molecular biomarkers within the context of tumor morphometry and clinical observations.
Our current offering, Prostate Px+, is a new prognostic test for newly-diagnosed prostate cancer patients and their physicians, which predict from their biopsy tissue how severe their disease is and the likelihood their cancer will recur if they opt for surgery. This information provided at diagnosis enables more informed treatment selection and appropriate counseling.